Wnt signaling and Dupuytren's disease.

Wnt signaling and Dupuytren's disease.

BACKGROUND: Dupuytren's disease is a benign fibromatosis of the hands and fingers that leads to flexion contractures. We hypothesized that multiple genetic and environmental factors influence susceptibility to this disease and sought to identify susceptibility genes to better understand its pa...

Bibliografiset tiedot
Päätekijät:	Dolmans, G, Werker, P, Hennies, H, Furniss, D, Festen, E, Franke, L, Becker, K, van der Vlies, P, Wolffenbuttel, B, Tinschert, S, Toliat, MR, Nothnagel, M, Franke, A, Klopp, N, Wichmann, H, Nürnberg, P, Giele, H, Ophoff, R, Wijmenga, C
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2011

Samankaltaisia teoksia

Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.
Tekijä: Kerstin Becker, et al.
Julkaistu: (2016-01-01)

A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis
Tekijä: Ng, M, et al.
Julkaistu: (2017)

Genome-wide association scan of Dupuytren's disease.
Tekijä: Furniss, D, et al.
Julkaistu: (2011)

Sibling recurrence risk in Dupuytren's disease.
Tekijä: Capstick, R, et al.
Julkaistu: (2013)

A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren’s disease
Tekijä: Sophie A. Riesmeijer, et al.
Julkaistu: (2024-01-01)

Surgery for Dupuytren's contracture of the fingers.
Tekijä: Rodrigues, J, et al.
Julkaistu: (2015)

A weighted genetic risk score predicts surgical recurrence independent of high-risk clinical features in Dupuytren’s disease
Tekijä: Riesmeijer, S, et al.
Julkaistu: (2019)

Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI
Tekijä: Major, M, et al.
Julkaistu: (2019)

The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales.
Tekijä: Khan, A, et al.
Julkaistu: (2004)

Is Dupuytren’s disease really a “disease of the Vikings”?
Tekijä: Ng, M, et al.
Julkaistu: (2019)

Imaging for Dupuytren disease: a systematic review of the literature
Tekijä: Sanne Molenkamp, et al.
Julkaistu: (2019-05-01)

Reduced WNT4 expression in normal skin fibroblasts leads to ‘Dupuytren-like’ changes in the transcriptome
Tekijä: Aoife O'Brien, et al.
Julkaistu: (2024-09-01)

Commentary on Larson et al. Genetic and environmental influences in Dupuytren's disease: A study of 30,330 Danish twin pairs
Tekijä: Furniss, D
Julkaistu: (2015)

Guillaume Dupuytren
Tekijä: Romina A Parquet
Julkaistu: (2013-01-01)

Dupuytren’s disease
Tekijä: Richard Trèves
Julkaistu: (2011-09-01)

Dupuytren's disease
Tekijä: Rames Mattar Junior
Julkaistu: (2008-03-01)

Nonsense-mediated decay and the molecular pathogenesis of mutations in SALL1 and GLI3.
Tekijä: Furniss, D, et al.
Julkaistu: (2007)

Treatment for Dupuytren's disease
Tekijä: Nanchahal, J, et al.
Julkaistu: (2013)

Paediatric Dupuytren's disease
Tekijä: Pradeoth Mukundan Korambayil, et al.
Julkaistu: (2011-09-01)

Enfermedad de Dupuytren
Tekijä: J. M. Arandes Renú
Julkaistu: (2010-11-01)

Enfermedad de Dupuytren
Tekijä: Jorge Badilla-Mora, et al.
Julkaistu: (2004-10-01)

Enfermedad de Dupuytren
Tekijä: Jorge Badilla-Mora, et al.
Julkaistu: (2004-10-01)

Enfermedad de Dupuytren
Tekijä: Jorge de Vecchi, et al.
Julkaistu: (2020-03-01)

Dupuytren’s disease. State of the art and therapeutic perspectives
Tekijä: F.P. Cantatore, et al.
Julkaistu: (2011-09-01)

Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells
Tekijä: Nataly Puerta Cavanzo, et al.
Julkaistu: (2022-08-01)

Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
Tekijä: Nanchahal, J, et al.
Julkaistu: (2022)

The relationship between body mass index and the risk of development of Dupuytren's disease: a Mendelian randomization study.
Tekijä: Majeed, M, et al.
Julkaistu: (2020)

Comparison of outcomes of peripheral nerve schwannoma excision in neurofibromatosis type 2 patients and non-neurofibromatosis type 2 patients: A case control study
Tekijä: Bendon, C, et al.
Julkaistu: (2015)

Modern surgical management of breast cancer therapy related upper limb and breast lymphoedema
Tekijä: Leung, N, et al.
Julkaistu: (2015)

Outcomes of peripheral nerve schwannoma excision in NF2 patients are as good as in non-NF2 patients - a case-control study
Tekijä: Bendon, C, et al.
Julkaistu: (2013)

Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. A population-based cohort analysis
Tekijä: Broekstra, DC, et al.
Julkaistu: (2022)

The prevalence of Dupuytren’s disease in patients with diabetes mellitus
Tekijä: Sandhya Ganesan, et al.
Julkaistu: (2023-07-01)

The incidence and prevalence of Dupuytren’s disease in primary care: results from a text mining approach on registration data
Tekijä: Roel J. M. van Straalen, et al.
Julkaistu: (2024-10-01)

Molecular genetics of Dupuytren’s contracture
Tekijä: Aissvarya, Shankar, et al.
Julkaistu: (2024)

The molecular genetics of dupuytren disease
Tekijä: Ng, M
Julkaistu: (2018)

The Hand Patient: Dupuytren's Contracture
Tekijä: U. Mennen
Julkaistu: (2001-04-01)

Molecular genetics of Dupuytren’s contracture
Tekijä: Shankar Aissvarya, et al.
Julkaistu: (2024-08-01)

Dupuytren’s Diathesis in an African Male
Tekijä: Richard Mbuva, et al.
Julkaistu: (2016-07-01)

Needle Aponeurotomy for Dupuytren's Contracture
Tekijä: HS Cheng, et al.
Julkaistu: (2008-04-01)

Heterotopic ossification in Dupuytren's disease: clinical and histological significance.
Tekijä: Sadideen, H, et al.
Julkaistu: (2011)